FDA 21 CFR Part 820 covers the processes used in, & the facilities & controls used for the design, manufacture, packaging, labelling, storage, installation & servicing of medical devices. Manufacturers are inspected by US FDA as per Part 820; however, there is no certification process for Part 820 & only compliance with the requirements is assessed. Operon Strategist does an initial gap analysis of the existing system to determine the extent of development of the quality system.
We provide 21 CFR 820 training in which we guide the clients through documentation & help them to effectively implement it through the various functions of the company.
We also conduct a mock audit to test the effectiveness of the implementation of Part 820 requirements. We also provide post-inspection guidance to clients to help them close any non-conformance observed during the audit.
FDA 21 CFR Part 820 helps manufacturers to build and follow quality systems to help assure that their products consistently meet applicable requirements and specifications.
The quality systems for FDA-regulated products (food, drugs, biologics, and devices) are known as Current Good Manufacturing Practices.
CGMP requirements for devices in part US FDA 21 CFR Part 820 (21 CFR part 820) were first authorized by section 520(f) of the Federal Food, Drug, and Cosmetic Act, FDA 21 CFR part 820 (QSR 21 CFR part 820 ) is USFDA current good manufacturing (CGMP) requirements for medical device manufacturers.
The FDA 21 CFR part 820 also known as Quality System Regulation i.e. FDA QSR which outlines current good manufacturing practice (CGMP) regulations that control the techniques used in and the efficiency and controls used for, the manufacturing, labeling, packaging, storage, installation, design, and servicing of all finished medical devices predetermined for human use and marketing in the United States Of America.
The above requirements are turned to ensure that medical devices are safe and effective produced by medical device manufacturers who support FDA(Food And Drugs Administration) inspections to assure FDA QSR (quality system regulation) 21 CFR part 820 compliance.
FDA 21 CFR Part 820 – Quality System Regulation
Are you prepared to sell your medical devices in the United States? Provided that this is true, your organization must conform to the US FDA QSR (Quality System Regulation), particularly known as 21 CFR Part 820.
Regardless of the possibility that you as of now have a quality management system must meet this regulation before you can sell your device.
FDA 21 CFR Part 820.30 Design Control Requirements
After conceptualizing a new medical device, the next step in its product advancement is the manufacturing plant layout design. This is the most important stage in the advancement of a medical device since a defective plan may prompt it being inadequate or dangerous (that is, not affirmed or cleared by the administrative organization).
At the design stage, an outline FDA 21 CFR Part 820 design control process should be started and actualized as a feature of the quality system requirement. Generally, outline controls are straightforward and logical steps to ensure that what you develop is what you meant to develop and that the last item lives up to your client’s needs and desires.
Operon Strategist assists companies and medical device manufacturers by providing consultancy services that support the registration of drug-device combination products. We have experience with each constituent part and the GMP regulations that together form the basis for their development and manufacture: Drug (21 CFR 210 and 211), Device (FDA 21 CFR part 820) and Combination Products (21 CFR Part 4).